Management Team

inouit — 2009-05-12T09:27:31Z

Drs. Hans Schram - CEO and Managing Director

Drs. Schram has a Chemistry degree from Leiden University in the Netherlands and over twenty years of experience in the global Pharmaceutical industry.
Prior to joining Nordic, he spent 18 years at Ferring, where he was a member of the Executive Management team.
Prior to Ferring, he was at Ciba Geigy and at Pierre Fabre Laboratories.
Drs. Schram joined the Nordic Group as the CEO and Managing Director in 2002.

The Nordic Group
216, boulevard St. Germain
75007 Paris
France
Tel. +33 1 53 63 88 77
Fax +33 1 45 48 76 50
info@nordicpharma.com

Stéphane Altaba, PhD, Director Corporate Business Development

Dr. Altaba has an engineering degree in Agronomy, a PhD in Biotechnology and a postgraduate degree in Management from the ESCP-EAP business school. For over 10 years, he had responsibilities in R&D and Industrial Affairs in RPR, and in Business Development within Aventis and Sanofi Aventis. In his last assignment at Sanofi Aventis, he was in charge of Corporate Business Development for the Oncology franchise. Dr. Altaba joined the Nordic Group in August 2006.

The Nordic Group
216, boulevard St. Germain
75007 Paris
France
Tel. +33 1 53 63 88 77
Fax +33 1 45 48 76 50
info@nordicpharma.com

Charlotte Phelps, General Manager of Nordic Pharma UK

After an early career in research, Ms. Phelps moved to the Pharmaceutical industry in mid-80’s. Following a successful time in sales, she moved to Global Marketing, where she was responsible for a number of product ranges including the launch of a new chemical entity in Obstetrics. Ms. Phelps has experience in a wide range of therapy areas, including Cardiovascular, Mental health, Endocrinology, Critical Care, Haematology and Obstetrics.
Ms. Phelps is responsible for establishing and running the Nordic UK affiliate as of mid-2002.

Nordic Pharma UK
Abbey House
1650 Arlington Business Park
Theale, Reading RG7 4SA
United Kingdom
+44 118 929 8233
+44 118 929 8234
info@nordicpharma.co.uk

Dr. Véronique Rebours-Mory, General Manager of Nordic Pharma FR

Dr Rebours-Mory is a Pharmaceutical doctor from the University of Lyon. She started her career in the late 80’s and has since developed her skills in Sales, Marketing, Operational Clinical Development, European Project Management, International Business Development, and General Management in fully integrated Pharmaceutical companies. She also has experience in several therapeutic areas, including Neurology, Infectious Diseases, Oncology, Gynaecology, Gastroenterology, Critical Care and Rheumatology. Dr. Rebours-Mory joined the Nordic Group in 2002 to create and develop Nordic’s French affiliate.

Nordic Pharma France
10, rue René Anjolvy
94250 Gentilly
France
Tel. +33 1 72 46 72 00
Fax +33 1 72 46 72 29
info@nordicpharma.com

Günter Lützenkirchen, General Manager of Nordic DE

Dr. Lützenkirchen has a background in Chemistry and Biology with a Ph.D. in Biology from the University of Freiburg/Brsg.
He started his marketing-based career as a Product Manager with Ciba-Geigy and Sandoz. He then held various positions of increasing responsibility in Marketing and General Management with Pharmacia and Searle, Antisense Pharma, and Brand Institute Germany. His most recent position in the pharmaceutical industry was as Managing Director of the German affiliate of Biogen Idec GmbH.
Dr. Lützenkirchen joined Nordic Group on July 1^st, 2008 as the General Manager of Nordic’s German affiliate.

Nordic Pharma Germany
Fraunhoferstr.4
85737 Ismaning
Germany
Tel. +49 89 889 690 680
info@nordicpharma.de

Ivana Stivinova, M.D, General Manager of Nordic Pharma CZ

Dr. Stivinova graduated as a medical doctor. She began working in the pharmaceutical industry over 15 years ago, when she joined Glaxo as sales representative.
Dr. Stivinova then spent nearly 10 years in Ferring both as a Product Manager and as a Marketing & Sales Manager in the Czech Republic. She eventually became an International Project Specialist in Ferring in Copenhagen and later the Marketing & Sales Manager for Central and Eastern Europe (based in Vienna).
Dr. Stivinova joined the Nordic Group in 2003 to manage the challenging job of General Manager, Nordic Pharma Czech Republic, as well as to oversee all Marketing and Sales activities there and in the rest of Central and Eastern Europe.

Nordic Pharma Czech Republic
Zachova
140 000 Prague 4 - Krc
Czech Republic
Tel. +420 241 029 544
info@nordicpharma.cz

Anders Löfgren, DDS, MBA, Managing Director of Nordic Drugs

Mr. Löfgren has a double qualification as a DDS (Doctor of Dental Surgery) and as an MBA. Mr. Löfgren is also a trained Army Officer with the rank of Captain.
Mr. Löfgren counts an impressive 18 years in the Pharmaceutical Industry in various well-known companies (Ciba-Geigy, Searle, Ferring). He has broad Marketing experience both in Scandinavia and in the rest of Europe.
Mr. Löfgren was one of the first to join the Nordic Group of companies, back in 1996.

Nordic Drugs Sweden
Geijersgatan 2 A
200 61 Limhamm
Sweden
Tel. +46 40 36 66 00
info@nordicdrugs.se

Paul Rohof, M.D., General Manager of Disphar

Disphar International
Tolweg 15
3741 LM Baarn
The Netherlands
Tel. +31 35 5280 403
Fax. +31 35 5480 585

Kenneth Stokholm, Managing Director of QPharma

Mr. Stokholm has a technical background in chemical engineering and holds an MSc. He joined the pharmaceutical industry in Novo Nordisk in Denmark and has since held various leading positions within Supply Chain and Operations as well as Project Management.
His last assignment was establishing a pharmaceutical facility for Alpharma in Taizhou, China, where he held the position as Managing Director. The facility was built, the organisation established and developed and the site is today in operation and approved by FDA.
Mr. Stokholm joined QPharma, and the Nordic Group, in January 2009.

QPharma
Agneslundsvägen 27
20 125 Malmö
Sweden
Tel. +46 40 36 18 00
Fax +46 40 18 28 55
info@qpharma.se

Petr Janda, MD, General Manager of Prague Clinical Services

Dr. Petr Janda is a medical doctor who graduated with specialisations in Internal Medicine and Nephrology from Charles Univesity in Prague, Czech Republic. He has over 16 years of experience in clinical studies, in particular within Ciba Geigy and Ferring. In the past, he was responsible for worldwide clinical activities from phase I – IV, as well as registration and pharmacovigilance activities.
Dr. Janda has been Managing Director of Prague Clinical Services since 2004 and under his guidance Prague Clinical Services has grown into one of the most prominent independent CROs in Central & Eastern Europe. Moreover, Dr. Janda is the President of ACRO-CZ (the Czech CRO Association) and a management team member of EUCROF (the European CRO Federation).

Prague Clinical Services
Zachova 8
140 00 Prague 4 – Krc
Czech Republic
Tel. +420 241 029 551
Fax. + 420 241 442 852
info@pragclin.com

Our vision

inouit — 2007-10-23T09:06:28Z

…To establish a pan-European speciality pharmaceutical group and to provide the highest quality international pharmaceutical products and services to our customers, partners and patients…

Our teams intend to continue developing the Nordic Group as a fully-integrated Pharmaceutical group with a strong European presence by respecting a number of core values and principles :

apply the highest ethical standards to our business conduct,
make our first responsibility our patients, their families, physicians, nurses and all other customers and stakeholders who use our products and services,
be responsible to our employees throughout the world,
be good citizens in the communities in which we live and work.

The Nordic vision includes offering its internal competencies and resources to third parties both as reliable services and as tools for building strategic partnerships. The various pharmaceutical service companies in the Nordic Group anticipate that their clients are entitled to expect a number of significant benefits by collaborating with Nordic, in particular in terms of speed, talent, reliability, efficiency, resources, excellence and IPR protection. Management and staff in the Nordic Group companies are fully committed to fulfilling these expectations.

History

inouit — 2007-10-23T08:49:43Z

The Nordic Group history began in 1995 with the establishment of the Nordic Drugs Marketing and Sales company in Sweden. The Nordic Drugs organisation then rapidly spread into other Scandinavian countries. Today, Nordic Drugs has a strong marketing presence in the four largest Scandinavian markets.

Over the following years, the Nordic Group expanded its range of activities and geographical reach by incorporating various pharmaceutical service companies in Sweden, the Netherlands and in the Czech Republic. At present, the Nordic Group is providing an extensive array of manufacturing, regulatory, clinical and industrial product supply services to pharmaceutical companies throughout Europe. Speciality pharmaceuticals developed and/or manufactured in the Nordic Group are now being marketed and distributed worldwide, including in the USA, Central & Eastern Europe, the Middle East and Asia.

The Nordic Group is committed to building a European-wide Marketing and Sales organisation. Since 2002, the Nordic Group has been gradually establishing Marketing and Sales entities in the various countries in Europe. These affiliates operate under the name Nordic Pharma.

To continue strengthening its activities and services, the Nordic Group is in the process of creating a new laboratory for product development in India - Indeus Life Sciences will become fully operational in 2009.

Nordic Pharma Group